Arlt, A., et al.,Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2)
Sept 2012
During the winter, many people experience lower energy, which can make it harder to get through the day
Home | Healthcare | GLP-1 Receptor Agonist Market Report by Product (Victoza, Ozempic, Trulicity, Bydureon, Saxenda, and Others), Route of Administration (Parenteral, Oral), Application (Type 2 Diabetes Mellitus, Obesity, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics, Online Pharmacies), and Region 2026-2034 Report Format: PDF+Excel | Report ID: SR112026A13049 Report Description Table of Contents Methodology Request Sample GLP-1 Receptor Agonist Market Size: The global GLP-1 receptor agonist market size reached USD 29.0 Billion in 2025
The most common adverse events are nausea and other gastrointestinal discomfort
People who are pregnant, vegan, or have certain medical conditions may have a higher risk of B vitamin deficiencies
